Risankizumab and upadacitinib in the treatment of psoriatic arthritis: different mechanisms, same goal [article in Italian]
Year: 2024
Type: article
Abstract: Gli autori
Source: Drugs in Context
DOI: 10.7573/dic.2024-7-3
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,901
OpenAlex ID: W4402992637
